New combo vaccine aims to knock out two salmonella threats
NCT ID NCT05480800
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tested a new vaccine designed to protect against two serious bacterial infections: typhoid fever and invasive nontyphoidal salmonella (iNTS). The trial involved 155 healthy adults in Europe and Africa to check the vaccine's safety and how well it triggers an immune response. Researchers gave three doses and monitored for side effects like pain, swelling, and fever.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SALMONELLA INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Edegem, 2650, Belgium
-
GSK Investigational Site
Blantyre, Malawi
Conditions
Explore the condition pages connected to this study.